Aurinia Pharmaceuticals(DE:IKAP)
€14.40-0.22 (-1.54%)
DE:IKAP
Aurinia Pharmaceuticals earnings date
€14.40
At close:-0.22 (-1.54%)
Aurinia Pharmaceuticals (IKAP) Q2 2023 Earnings Report
1 Followers
DE:IKAP Q2 2023 EPS Results
- Actual EPS
- -EUR 0.07
- Consensus EPS
- -EUR 0.16
- Beat/Miss
- Beat by +EUR 0.09
- One Year Ago EPS
- -EUR 0.22
DE:IKAP Q2 2023 Revenue Results
- Actual Revenue
- EUR 36.91M
- Expected Revenue
- EUR 33.71M
- Beat/Miss
- Beat by +EUR 3.20M
- YoY Revenue Growth
- +47.19%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/03/2023
- Time
- Before Open
- Conference Call
- Thursday, August 3, 2023
DE:IKAP Upcoming Earnings
Aurinia Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:IKAP Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:IKAP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | 0.19- | 1.36 | ― | ― |
| Oct 30, 2026 | 2026 (Q3) | 0.200.20 | 0.2 | 0.00% (+0.00) | |
| Aug 06, 2026 | 2026 (Q2) | 0.210.25 | 0.14 | 75.00% (+0.11) | |
| May 07, 2026 | 2026 (Q1) | 0.170.22 | 0.14 | 56.25% (+0.08) | |
| Feb 26, 2026 | 2025 (Q4) | 0.191.36 | 0.01 | 15200.00% (+1.35) | |
| Nov 04, 2025 | 2025 (Q3) | 0.140.20 | 0.09 | 130.00% (+0.12) | |
| Jul 31, 2025 | 2025 (Q2) | 0.130.14 | 0.01 | 1500.00% (+0.13) | |
| May 12, 2025 | 2025 (Q1) | 0.090.14 | -0.06 | 328.57% (+0.20) | |
| Feb 27, 2025 | 2024 (Q4) | -0.010.01 | -0.17 | 105.26% (+0.18) | |
| Nov 07, 2024 | 2024 (Q3) | 0.010.09 | -0.08 | 211.11% (+0.17) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
